Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
40.94
+0.94 (2.35%)
Jun 18, 2026, 4:08 PM HKT

HKG:2315 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
41,22523,5853,3954,78510,245-
Market Cap Growth
571.11%594.71%-29.05%-53.29%--
Enterprise Value
40,96023,8593,5624,68210,003-
Last Close Price
40.9435.308.5011.9825.65-
PE Ratio
50.28122.3795.11---
PS Ratio
23.2115.373.256.0616.97-
PB Ratio
15.869.723.805.507.87-
P/TBV Ratio
16.269.994.135.738.12-
P/FCF Ratio
121.5075.0418.32---
P/OCF Ratio
75.3857.2415.10---
EV/Sales Ratio
23.0615.553.415.9316.57-
EV/EBITDA Ratio
77.3967.8813.92---
EV/EBIT Ratio
107.83101.5125.51---
EV/FCF Ratio
120.7275.9119.23---
Debt / Equity Ratio
0.440.270.680.690.360.07
Debt / EBITDA Ratio
2.131.702.14---
Debt / FCF Ratio
3.332.073.28---
Net Debt / Equity Ratio
-0.10-0.460.200.14-0.20-0.39
Net Debt / EBITDA Ratio
-0.54-3.170.69-0.710.491.16
Net Debt / FCF Ratio
-0.79-3.540.96-0.540.420.86
Asset Turnover
-0.450.400.270.210.15
Inventory Turnover
-2.493.7412.256.096.11
Quick Ratio
2.292.051.201.011.251.55
Current Ratio
2.702.311.531.251.521.96
Return on Equity (ROE)
18.59%11.48%4.12%-39.45%-50.12%-40.27%
Return on Assets (ROA)
-4.30%3.37%-6.94%-14.81%-14.02%
Return on Invested Capital (ROIC)
19.72%17.82%10.76%-31.99%-71.53%-76.89%
Return on Capital Employed (ROCE)
11.10%7.60%7.00%-15.60%-27.60%-28.00%
Earnings Yield
0.80%0.82%1.05%-8.82%-6.64%-
FCF Yield
0.82%1.33%5.46%-4.68%-6.00%-
Payout Ratio
5.08%8.69%45.29%---
Buyback Yield / Dilution
5.72%3.93%-5.26%-4.54%-5.13%-180.82%